From "serum sickness" to "xenosialitis": past, present, and future significance of the non-human sialic acid Neu5Gc
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If anti-Neu5Gc antibodies bind to human cells, they may lead to inflammation and possibly carcinogenesis and atherogenesis, termed xenosialitis”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Dhar et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Micha, R., Wallace, S. K., & Mozaffarian, D. (2010) · Circulation · doi:10.1161/circulationaha.109.924977 · Cited by 1,244
Lopez-Garcia, E., Schulze, M. B., Fung, T. T., Meigs, J. B., Rifai, N., Manson, J. E., & Hu, F. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.1029 · Cited by 881
Red Meat Consumption and Mortality: Results From 2 Prospective Cohort Studies
Sun, Q. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2287 · Cited by 763
Pan, A., Sun, Q., Bernstein, A. M., Schulze, M. B., Manson, J. E., Willett, W. C., & Hu, F. B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018978 · Cited by 709
Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid
Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., & Muchmore, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131556100 · Cited by 625
Self-citationMicha, R., Michas, G., & Mozaffarian, D. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0282-8 · Cited by 502 · cited 1×
“There is a clear association between consumption of red meats and processed meats with increased risk of CVD in humans (131, 153).”
BackgroundImplications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
Ghaderi, D., Taylor, R. E., Padler-Karavani, V., Diaz, S., & Varki, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1651 · Cited by 372
Self-citationGhaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A. (2012) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-28-147 · Cited by 320 · cited 1×
“Glycosylation of these antibodies may involve Neu5Gc-rich media and/or mammalian cells that express Neu5Gc (186).”
BackgroundSelf-citation
Research works printed but not linked: 177
- Jackson, 2000, Serum sickness, J Cutan Med Surg., 4, 223, 10.1177/120347540000400411 · doi:10.1177/120347540000400411
- Bolton, 1899, The complications of the serum treatment of diptheria, Lancet., 153, 891, 10.1016/S0140-6736(01)68368-5 · doi:10.1016/s0140-6736(01)68368-5
- Pirquet, 1905, Die Serumkrankheit.
- Hanganutziu, 1924, Hémagglutinines hétérogénétiques après injection de sérum de cheval, CR Séances Soc Biol., 91, 1457
- Deicher, 1926, Über die Erzeugung heterospezifischer Hämagglutinine durch Injektion artfremden, Serums Z Hyg., 106, 561, 10.1007/BF02176298 · DOI
- Kasukawa, 1976, Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera, Clin Exp Immunol., 25, 122
- Higashi, 1977, Antigen of “serum sickness” type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid, Biochem Biophys Res Commun., 79, 388, 10.1016/0006-291X(77)90169-3 · DOI · Paper page
- Merrick, 1978, Characterization of the hanganutziu-deicher (serum-sickness) antigen as gangliosides containing n-glycolylneuraminic acid, Int Arch Allergy Appl Immunol., 57, 477, 10.1159/000232140 · DOI · Paper page
- Schauer, 1968, On biosynthesis of the glycolyl groups of N-glycolylneuraminic acid Oxidative conversion of N-acetyl groups to glycolyl groups, Hoppe Seylers Z Physiol Chem., 349, 645, 10.1515/bchm2.1968.349.1.645 · DOI
- Shaw, 1988, The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid, Biol Chem Hoppe Seyler., 369, 477, 10.1515/bchm3.1988.369.1.477 · DOI · Paper page
- Muchmore, 1989, Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool, J Biol Chem., 264, 20216, 10.1016/S0021-9258(19)47049-X · DOI · Paper page
- Kozutsumi, 1990, Participation of cytochrome b5 in CMP-N-acetylneuraminic acid hydroxylation in mouse liver cytosol, J Biochem., 108, 704, 10.1093/oxfordjournals.jbchem.a123268 · DOI · Paper page
- Kozutsumi, 1991, Reconstitution of CMP-N-acetylneuraminic acid hydroxylation activity using a mouse liver cytosol fraction and soluble cytochrome b5 purified from horse erythrocytes, J Biochem., 110, 429, 10.1093/oxfordjournals.jbchem.a123598 · DOI · Paper page
- Nishimaki, 1978, Studies on heterophile antibodies in rheumatoid arthritis, Arthritis Rheum., 21, 634, 10.1002/art.1780210604 · DOI
- Nishimaki, 1978, Studies on immune complexes in rheumatoid arthritis, Arthritis Rheum., 21, 639, 10.1002/art.1780210605 · DOI
- Nishimaki, 1979, Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues, J Immunol., 122, 2314, 10.4049/jimmunol.122.6.2314 · DOI · Paper page
- Morito, 1982, Hanganutziu-deicher antibodies in infectious mononucleosis and other diseases, J Immunol., 129, 2524, 10.4049/jimmunol.129.6.2524 · DOI · Paper page
- Ikuta, 1982, Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence, Biken J., 25, 47
- Arita, 1982, Heterophile Hanganutziu-deicher antibodies in sera of patients with kawasaki diseases, Biken J., 25, 157
- Takiguchi, 1984, Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies, Clin Exp Immunol., 56, 345
- Mukuria, 1986, A specific enzyme-linked immunosorbent assay (ELISA) procedure for detection of heterophile Hanganutziu and Deicher (HD) antibodies, J Immunol Methods., 86, 179, 10.1016/0022-1759(86)90450-3 · DOI
- Morito, 1986, Studies on Hanganutziu-Deicher antigens-antibodies. I. Hanganutziu-Deicher antibodies of IgG class in liver diseases, Int Arch Allergy Appl Immunol., 81, 204, 10.1159/000234135 · DOI · Paper page
- Nakarai, 1987, Expression of heterophile, Paul-Bunnell and Hanganutziu-Deicher antigens on human melanoma cell lines, Int Arch Allergy Appl Immunol., 83, 160, 10.1159/000234349 · DOI
- Higashihara, 1991, Survey of Hanganutziu and Deicher antibodies in operated patients, Int Arch Allergy Appl Immunol., 95, 231, 10.1159/000235434 · DOI · Paper page
- Higashi, 1984, Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers, Gann., 75, 1025
- Ohashi, 1983, Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells, Am J Ophthalmol., 96, 321, 10.1016/S0002-9394(14)77822-5 · DOI
- Higashi, 1984, Sensitive enzyme-immunostaining and densitometric determination on thin-layer chromatography of N-glycolylneuraminic acid-containing glycosphingolipids, Hanganutziu-Deicher antigens, J Biochem, 95, 1517, 10.1093/oxfordjournals.jbchem.a134760 · DOI
- Mukuria, 1985, A potential radioimmunoassay system for detection of Hanganutziu-Deicher type heterophile antigen(s) and antibodies in tissues and fluids, J Immunol Methods., 80, 97, 10.1016/0022-1759(85)90168-1 · DOI
- Higashi, 1985, Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer, Cancer Res., 45, 3796
- Nowak, 1986, Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum, Mol Immunol., 23, 693, 10.1016/0161-5890(86)90079-9 · DOI
- Mukuria, 1986, Microstructure of the sialic acid moiety of N-glycolylneuraminyllactosylceramide and the elucidation of Hanganutziu and Deicher (HD) antigenicity, Immunol Lett., 12, 165, 10.1016/0165-2478(86)90100-8 · DOI
- Kawachi, 1988, Heterophile Hanganutziu-Deicher antigen in ganglioside fractions of human melanoma tissues, Int Arch Allergy Appl Immunol., 85, 381, 10.1159/000234536 · DOI
- Fukui, 1989, Detection of glycoproteins as tumor-associated Hanganutziu-Deicher antigen in human gastric cancer cell line, NUGC4, Biochem Biophys Res Commun., 160, 1149, 10.1016/S0006-291X(89)80123-8 · DOI
- Nakarai, 1990, Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma, Int Arch Allergy Appl Immunol., 91, 323, 10.1159/000235135 · DOI
- Saida, 1990, Immunohistochemical detection of heterophile Hanganutziu-Deicher antigen in human malignant melanoma, Arch Dermatol Res., 282, 179, 10.1007/BF00372619 · DOI
- Diaz, 2009, Sensitive and specific detection of the non-human sialic acid N-glycolylneuraminic acid in human tissues and biotherapeutic products, PLoS ONE., 4, e4241, 10.1371/journal.pone.0004241 · DOI · Paper page
- Pham, 2009, Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium, Blood., 114, 5225, 10.1182/blood-2009-05-220400 · DOI · Paper page
- Irie, 1998, The molecular basis for the absence of N-glycolylneuraminic acid in humans, J Biol Chem., 273, 15866, 10.1074/jbc.273.25.15866 · DOI · Paper page
- Chou, 1998, A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence, Proc Natl Acad Sci USA., 95, 11751, 10.1073/pnas.95.20.11751 · DOI · Paper page
- Hayakawa, 2001, Alu-mediated inactivation of the human CMP- N-acetylneuraminic acid hydroxylase gene, Proc Natl Acad Sci USA., 98, 11399, 10.1073/pnas.191268198 · DOI · Paper page
- Chou, 2002, Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution, Proc Natl Acad Sci USA., 99, 11736, 10.1073/pnas.182257399 · DOI · Paper page
- Muchmore, 1998, A structural difference between the cell surfaces of humans and the great apes, Am J Phys Anthropol., 107, 187, 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.0.CO;2-S · doi:10.1002/(sici)1096-8644(199810)107:2<187::aid-ajpa5>3.0.co;2-s
- Varki, 2009, Human-specific evolution of sialic acid targets: explaining the malignant malaria mystery, Proc Natl Acad Sci USA., 106, 14739, 10.1073/pnas.0908196106 · DOI · Paper page
- Bergfeld, 2017, N-glycolyl groups of nonhuman chondroitin sulfates survive in ancient fossils, Proc Natl Acad Sci USA., 114, E8155, 10.1073/pnas.1706306114 · DOI
- Ma, 2016, A mouse model for dietary xenosialitis: antibodies to xenoglycan can reduce fertility, J Biol Chem., 291, 18222, 10.1074/jbc.M116.739169 · DOI
- Schauer, 2009, Low incidence of N-glycolylneuraminic acid in birds and reptiles and its absence in the platypus, Carbohydr Res., 344, 1494, 10.1016/j.carres.2009.05.020 · DOI
- Peri, 2018, Phylogenetic distribution of CMP-Neu5Ac hydroxylase (CMAH), the enzyme synthetizing the proinflammatory human xenoantigen Neu5Gc, Genome Biol Evol., 10, 207, 10.1093/gbe/evx251 · DOI · Paper page
- Hedlund, 2008, Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression, Proc Natl Acad Sci USA., 105, 18936, 10.1073/pnas.0803943105 · DOI · Paper page
- Oetke, 2001, Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells, Eur J Biochem., 268, 4553, 10.1046/j.1432-1327.2001.02379.x · DOI · Paper page
- Hedlund, 2007, N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution, Mol Cell Biol., 27, 4340, 10.1128/MCB.00379-07 · DOI · Paper page
- Samraj, 2015, A red meat-derived glycan promotes inflammation and cancer progression, Proc Natl Acad Sci USA., 112, 542, 10.1073/pnas.1417508112 · DOI · Paper page
- Schauer, 1982, Chemistry, metabolism, and biological functions of sialic acids, Adv Carbohydr Chem Biochem., 40, 131, 10.1016/S0065-2318(08)60109-2 · DOI · Paper page
- Warren, 1963, The distribution of sialic acids in nature, Comp Biochem Physiol., 10, 153, 10.1016/0010-406X(63)90238-X · DOI · Paper page
- Malykh, 1999, The presence of N-acetylneuraminic acid in Malpighian tubules of larvae of the cicada Philaenus spumarius, Glycoconjugate J., 16, 731, 10.1023/A:1007115627708 · doi:10.1023/a:1007115627708
- Roth, 1992, Occurrence of sialic acids in Drosophila melanogaster, Science., 256, 673, 10.1126/science.1585182 · doi:10.1126/science.1585182
- Schauer, 2018, Exploration of the sialic acid world, Adv Carbohydr Chem Biochem., 75, 1, 10.1016/bs.accb.2018.09.001 · DOI · Paper page
- Wang, 2012, Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition, Adv Nutr., 3, 465S, 10.3945/an.112.001875 · DOI · Paper page
- Chen, 2013, LC-MS/MS quantification of N-acetylneuraminic acid, N-glycolylneuraminic acid and ketodeoxynonulosonic acid levels in the urine and potential relationship with dietary sialic acid intake and disease in 3- to 5-year-old children, Br J Nutr., 111, 1, 10.1017/S0007114513002468 · DOI
- Padler-Karavani, 2008, Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease, Glycobiology., 18, 818, 10.1093/glycob/cwn072 · DOI · Paper page
- Banda, 2012, Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid, J Biol Chem., 287, 28852, 10.1074/jbc.M112.364182 · DOI · Paper page
- Nöhle, 1984, Metabolism of sialic acids from exogenously administered sialyllactose and mucin in mouse and rat, Hoppe Seylers Z Physiol Chem., 365, 1457, 10.1515/bchm2.1984.365.2.1457 · DOI
- Bardor, 2005, Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells, J Biol Chem., 280, 4228, 10.1074/jbc.M412040200 · DOI · Paper page
- Kabat, 1988, The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV, J Exp Med., 168, 699, 10.1084/jem.168.2.699 · DOI
- Frei, 2018, Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis, J Allergy Clin Immunol., 141, 382, 10.1016/j.jaci.2017.04.051 · DOI
- Bergfeld, 2012, Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid, J Biol Chem., 287, 28865, 10.1074/jbc.M112.363549 · DOI · Paper page
- Clausen, 2016, Oncofetal chondroitin sulfate glycosaminoglycans are key players in integrin signaling and tumor cell motility, Mol Cancer Res., 14, 1288, 10.1158/1541-7786.MCR-16-0103 · DOI
- Agerbaek, 2017, Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration, Int J Cancer., 140, 1597, 10.1002/ijc.30575 · DOI
- Agerbæk, 2018, Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites, Trends Parasitol., 35, 178, 10.1016/j.pt.2018.11.004 · DOI
- Agerbæk, 2018, The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner, Nat Commun., 9, 3279, 10.1038/s41467-018-05793-2 · DOI · Paper page
- Zhu, 2002, Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum, Xenotransplantation., 9, 376, 10.1034/j.1399-3089.2002.02138.x · DOI · Paper page
- Nguyen, 2005, Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells, J Immunol., 175, 228, 10.4049/jimmunol.175.1.228 · DOI · Paper page
- Tahara, 2010, Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice, J Immunol., 184, 3269, 10.4049/jimmunol.0902857 · DOI · Paper page
- Taylor, 2010, Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid, J Exp Med., 207, 1637, 10.1084/jem.20100575 · DOI · Paper page
- Ochsenbein, 2000, Natural antibodies and complement link innate and acquired immunity, Immunol Today., 21, 624, 10.1016/S0167-5699(00)01754-0 · DOI · Paper page
- Lu, 2012, LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion, Anal Chem., 84, 2761, 10.1021/ac2030893 · DOI
- Naito, 2007, Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation, Mol Cell Biol., 27, 3008, 10.1128/MCB.02047-06 · DOI · Paper page
- Cariappa, 2009, B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase, J Exp Med., 206, 125, 10.1084/jem.20081399 · DOI · Paper page
- Azuma, 1970, Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey, Biochim Biophys Acta., 208, 444, 10.1016/0304-4165(70)90217-5 · DOI
- Essers, 1978, Evidence for the incorporation of molecular oxygen, a pathway in biosynthesis of N-glycolylmuramic acid in Mycobacterium phlei, Biochim Biophys Acta., 544, 180, 10.1016/0304-4165(78)90221-0 · doi:10.1016/0304-4165(78)90221-0
- Raymond, 2005, Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan, J Biol Chem., 280, 326, 10.1074/jbc.M411006200 · DOI · Paper page
- Mahapatra, 2008, Unique structural features of the peptidoglycan of Mycobacterium leprae, J Bacteriol., 190, 655, 10.1128/JB.00982-07 · DOI · Paper page
- Coulombe, 2009, Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide, J Exp Med., 206, 1709, 10.1084/jem.20081779 · DOI · Paper page
- Daryaee, 2009, Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides, Eur J Med Chem., 44, 289, 10.1016/j.ejmech.2008.02.022 · DOI
- Vamecq, 1990, Studies on the metabolism of glycolyl-CoA, Biochem Cell Biol., 68, 846, 10.1139/o90-125 · DOI
- Vamecq, 1992, Subcellular distribution of glycolyltransferases in rodent liver and their significance in special reference to the synthesis of N-glycolyneuraminic acid, J Biochem., 111, 579, 10.1093/oxfordjournals.jbchem.a123800 · DOI
- Wang, 1993, Modeling study of antibody combining sites to (α1-6)dextrans. Predictions of the conformational contribution of VL-CDR3 and Jkappa segments to groove-type combining sites, J Biol Chem., 268, 20584, 10.1016/S0021-9258(20)80765-0 · DOI
- Klebert, 1993, Primary structure of the murine monoclonal IgG2a antibody mAb735 against (2-8) polysialic acid, Biol Chem Hoppe Seyler., 374, 993, 10.1515/bchm3.1993.374.7-12.993 · doi:10.1515/bchm3.1993.374.7-12.993
- Eleftheriou, 2014, Prevalence of anti-Neu5Gc antibodies in patients with hypothyroidism, Biomed Res Int., 2014, 963230, 10.1155/2014/963230 · DOI
- Hurh, 2016, Human antibody reactivity against xenogeneic N-glycolylneuraminic acid and galactose-α-1,3-galactose antigen, Xenotransplantation., 23, 279, 10.1111/xen.12239 · DOI
- Gong, 2018, Immunochromatographic strip biosensor for the rapid detection of N-glycolylneuraminic acid based on aptamer-conjugated nanoparticle, Anal Biochem., 2, 52, 10.1016/j.ab.2018.07.017 · DOI
- Padler-Karavani, 2011, Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer, Cancer Res., 71, 3352, 10.1158/0008-5472.CAN-10-4102 · DOI · Paper page
- Samraj, 2018, Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk, PLoS ONE., 13, e0197464, 10.1371/journal.pone.0197464 · DOI · Paper page
- Bashir, 2018, Presentation mode of glycans affect recognition of human serum anti-Neu5Gc IgG antibodies, Bioconjug Chem., 30, 161, 10.1021/acs.bioconjchem.8b00817 · DOI
- Apicella, 2012, Nontypeable Haemophilus influenzae: the role of N-acetyl-5-neuraminic acid in biology, Front Cell Infect Microbiol., 2, 19, 10.3389/fcimb.2012.00019 · DOI
- Carr, 2002, In vivo and in vitro anti-tumor effect of 14F7 monoclonal antibody, Hybrid Hybridomics., 21, 463, 10.1089/153685902321043990 · doi:10.1089/153685902321043990
- Rodríguez, 2003, Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside, Hybrid Hybridomics., 22, 307, 10.1089/153685903322538836 · doi:10.1089/153685903322538836
- Díaz, 2003, Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides, Clin Immunol., 107, 80, 10.1016/S1521-6616(03)00036-6 · doi:10.1016/s1521-6616(03)00036-6
- Hernández, 2005, Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: a self versus non-self-matter, Immunobiology., 210, 11, 10.1089/153685903322328947 · doi:10.1089/153685903322328947
- Leon, 2005, Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells, Cancer Immunol Immunother., 55, 443, 10.1007/s00262-005-0041-6 · doi:10.1007/s00262-005-0041-6
- Oliva, 2006, Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc, Breast Cancer Res Treat., 96, 115, 10.1007/s10549-005-9064-0 · doi:10.1007/s10549-005-9064-0
- Neninger, 2007, Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial, Cancer Biol Ther., 6, 145, 10.4161/cbt.6.2.3574 · doi:10.4161/cbt.6.2.3574
- Labrada, 2010, Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy, Expert Opin Biol Ther., 10, 153, 10.1517/14712590903443084 · DOI
- Fernandez, 2010, NGcGM3 ganglioside: a privileged target for cancer vaccines, Clin Dev Immunol., 2010, 814397, 10.1155/2010/814397 · DOI
- Vázquez, 2012, Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data, Front Oncol., 2, 150, 10.3389/fonc.2012.00150 · DOI
- Blanco, 2013, Immunoreactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in primary lymphoid tumors and lymph node metastasis, Patholog Res Int., 2013, 920972, 10.1155/2013/920972 · DOI
- Blanco, 2013, Tissue Reactivity of the 14F7 mab raised against n-glycolyl GM3 ganglioside in tumors of neuroectodermal, mesodermal, and epithelial origin, J Biomark., 2013, 602417, 10.1155/2013/602417 · DOI
- Palomo, 2016, Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications, Clin Exp Metastasis., 33, 717, 10.1007/s10585-016-9811-0 · DOI
- Labrada, 2018, GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy, Semin Oncol., 45, 41, 10.1053/j.seminoncol.2018.04.003 · DOI
- de, 2014, Cancer vaccine characterization: from bench to clinic, Vaccine., 32, 2851, 10.1016/j.vaccine.2014.02.017 · DOI
- Gajdosik, 2014, Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer, Drugs Today., 50, 301, 10.1358/dot.2014.50.4.2116670 · doi:10.1358/dot.2014.50.4.2116670
- Bousquet, 2018, Hypothesis: hypoxia induces de novo synthesis of NeuGc gangliosides in humans through CMAH domain substitute, Biochem Biophys Res Commun., 495, 1562, 10.1016/j.bbrc.2017.11.183 · DOI
- Bada, 2002, Toxicity of a GM3 cancer vaccine in Macaca fascicularis monkey: a 12-month study, Hum Exp Toxicol., 21, 263, 10.1191/0960327102ht248oa · doi:10.1191/0960327102ht248oa
- Amon, 2017, Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy, Oncotarget., 8, 112236, 10.18632/oncotarget.23096 · DOI
- Couvrat-Desvergnes, 2015, Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival, J Clin Invest., 125, 4655, 10.1172/JCI82267 · DOI · Paper page
- Okamura, 2007, Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells, J Neuroimmunol., 192, 134, 10.1016/j.jneuroim.2007.09.030 · DOI
- Salama, 2017, Anti-Gal and Anti-Neu5Gc responses in nonimmunosuppressed patients after treatment with rabbit antithymocyte polyclonal IgGs, Transplantation., 101, 2501, 10.1097/TP.0000000000001686 · DOI
- Pearce, 2014, Hormesis in cancer immunology: does the quantity of an immune reactant matter, Oncoimmunology., 3, e29312, 10.4161/onci.29312 · DOI
- Pearce, 2014, Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies, Proc Natl Acad Sci USA., 111, 5998, 10.1073/pnas.1209067111 · DOI · Paper page
- Marquina, 1996, Gangliosides expressed in human breast cancer, Cancer Res., 56, 5165
- Carr, 2000, A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors, Hybridoma., 19, 241, 10.1089/02724570050109639 · DOI
- Giovannucci, 1994, Intake of fat, meat, and fiber in relation to risk of colon cancer in men, Cancer Res., 54, 2390
- Stavric, 1994, Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review, Food Chem Toxicol., 32, 977, 10.1016/0278-6915(94)90093-0 · DOI
- Santarelli, 2008, Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence, Nutr Cancer., 60, 131, 10.1080/01635580701684872 · DOI · Paper page
- Lamberto, 2014, Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients, Genome Announc., 2, e00848, 10.1128/genomeA.00848-14 · DOI
- Zur Hausen, 2017, Infectious agents in bovine red meat and milk and their potential role in cancer and other chronic diseases, Curr Top Microbiol Immunol., 407, 83, 10.1007/82_2017_3 · DOI
- Falida, 2017, Isolation of two virus-like circular DNAs from commercially available milk samples, Genome Announc., 5, e00266, 10.1128/genomeA.00266-17 · doi:10.1128/genomea.00266-17
- Zur Hausen, 2018, Specific nutritional infections early in life as risk factors for human colon and breast cancers several decades later, Int J Cancer., 144, 1574, 10.1002/ijc.31882 · DOI
- Coussens, 2013, Neutralizing tumor-promoting chronic inflammation: a magic bullet?, Science, 339, 286, 10.1126/science.1232227 · DOI · Paper page
- Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet., 357, 539, 10.1016/S0140-6736(00)04046-0 · DOI · Paper page
- Grivennikov, 2010, Immunity, inflammation, and cancer, Cell., 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell., 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Mantovani, 2008, Cancer-related inflammation, Nature., 454, 436, 10.1038/nature07205 · DOI · Paper page
- Wang, 2007, Inflammatory mediators and nuclear receptor signaling in colorectal cancer, Cell Cycle., 6, 682, 10.4161/cc.6.6.4030 · DOI · Paper page
- Yin, 2006, Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells, Cancer Res., 66, 2937, 10.1158/0008-5472.CAN-05-2615 · DOI · Paper page
- Hedlund, 2008, alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo, Cancer Res., 68, 388, 10.1158/0008-5472.CAN-07-1340 · DOI · Paper page
- Soulillou, 2018, No increase in Colon cancer risk following induction with Neu5Gc-bearing rabbit Anti-T Cell IgG (ATG) in recipients of kidney transplants, Cancers., 10, E324, 10.3390/cancers10090324 · DOI
- Grundy, 1999, Diabetes and cardiovascular disease: a statement for healthcare professionals from the American heart association, Circulation., 100, 1134, 10.1161/01.CIR.100.10.1134 · DOI · Paper page
- Varki, 2009, Heart disease is common in humans and chimpanzees, but is caused by different pathological processes, Evol Appl., 2, 101, 10.1111/j.1752-4571.2008.00064.x · DOI · Paper page
- Swirski, 2013, Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure, Science., 339, 161, 10.1126/science.1230719 · DOI · Paper page
- Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat Med., 19, 576, 10.1038/nm.3145 · DOI · Paper page
- Balla, 1991, Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury, Arterioscler Thromb., 11, 1700, 10.1161/01.ATV.11.6.1700 · DOI · Paper page
- Balla, 1993, Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury, Trans Assoc Am Phys., 106, 128
- Belcher, 1993, Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro, Arterioscler Thromb., 13, 1779, 10.1161/01.ATV.13.12.1779 · DOI · Paper page
- Nagy, 2010, Red cells, hemoglobin, heme, iron, and atherogenesis, Arterioscler Thromb Vasc Biol., 30, 1347, 10.1161/ATVBAHA.110.206433 · DOI · Paper page
- Rabinovich, 2012, Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer, Immunity., 36, 322, 10.1016/j.immuni.2012.03.004 · DOI · Paper page
- Fuster, 2005, The sweet and sour of cancer: glycans as novel therapeutic targets, Nat Rev Cancer., 5, 526, 10.1038/nrc1649 · DOI · Paper page
- Yonezawa, 1992, Sialosyl-Tn antigen: Its distribution in normal human tissues and expression in adenocarcinomas, Am J Clin Pathol., 98, 167, 10.1093/ajcp/98.2.167 · DOI
- Ogata, 1998, Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa, Glycoconj J., 15, 29, 10.1023/A:1006935331756 · DOI
- Kobayashi, 1992, Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer, J Clin Oncol., 10, 95, 10.1200/JCO.1992.10.1.95 · DOI · Paper page
- Imai, 2001, Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma, Anticancer Res., 21, 1327
- Kim, 2002, Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas, Gastroenterology., 123, 1052, 10.1053/gast.2002.36018 · DOI · Paper page
- Conze, 2010, MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas, Glycobiology., 20, 199, 10.1093/glycob/cwp161 · DOI
- Cao, 1996, Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study, Histochem Cell Biol., 106, 197, 10.1007/BF02484401 · DOI · Paper page
- Starbuck, 2018, Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau, Oncotarget., 9, 23289, 10.18632/oncotarget.25289 · DOI
- Eavarone, 2018, Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma, PLoS ONE., 13, e0201314, 10.1371/journal.pone.0201314 · DOI
- Carr, 2003, Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine, J Clin Oncol., 21, 1015, 10.1200/JCO.2003.02.124 · DOI
- Fernández-Marrero, 2011, Fernandez- A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates, Immunobiology., 216, 1239, 10.1016/j.imbio.2011.07.004 · DOI
- Hernández, 2008, Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody, J Immunol., 181, 6625, 10.4049/jimmunol.181.9.6625 · DOI · Paper page
- Segatori, 2018, Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients, Cancer Immunol Immunother., 67, 1285, 10.1007/s00262-018-2188-y · DOI
- Scursoni, 2010, Detection and characterization of N-glycolyated gangliosides in wilms tumor by immunohistochemistry, Pediatr Dev Pathol., 13, 18, 10.2350/08-10-0544.1 · DOI
- Scursoni, 2011, Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer, Clin Dev Immunol., 2011, 245181, 10.1155/2011/245181 · DOI
- Blanco, 2011, Immunohistochemical reactivity of the 14F7 monoclonal antibody raised against N-Glycolyl GM3 ganglioside in some benign and malignant skin neoplasms, ISRN Dermatol., 2011, 848909, 10.5402/2011/848909 · DOI
- Blanco, 2011, Immunoreactivity of the 14F7 mab raised against N-Glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system, ISRN Gastroenterol., 2011, 645641, 10.5402/2011/645641 · DOI
- Blanco, 2012, Immunoreactivity of the 14F7 Mab (raised AGAINST N-Glycolyl Gm3 ganglioside) as a positive prognostic factor in non-small-cell lung cancer, Patholog Res Int., 2012, 235418, 10.1155/2012/235418 · DOI
- Leviatan, 2017, Profiling anti-Neu5Gc IgG in human sera with a sialoglycan microarray assay, J Vis Exp., 125, e56094, 10.3791/56094 · DOI
- Amon, 2018, A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen, Sci Rep., 8, 10786, 10.1038/s41598-018-29209-9 · DOI
- Sliwkowski, 2013, Antibody therapeutics in cancer, Science., 341, 1192, 10.1126/science.1241145 · DOI · Paper page
- Bandera, 2007, Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis, Cancer Causes Control., 18, 967, 10.1007/s10552-007-9038-0 · DOI
- Wallace, 2009, The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum, Cancer Epidemiol Biomarkers Prev., 18, 2310, 10.1158/1055-9965.EPI-09-0211 · DOI · Paper page
- McCullough, 2013, Association between red and processed meat intake and mortality among colorectal cancer survivors, J Clin Oncol., 31, 2773, 10.1200/JCO.2013.49.1126 · DOI
- Kim, 2018, Meat consumption and risk of metabolic syndrome: results from the Korean population and a meta-analysis of observational studies, Nutrients., 10, 10.3390/nu10040390 · DOI · Paper page
- Ludwig, 2005, Biomarkers in cancer staging, prognosis and treatment selection, Nat Rev Cancer., 5, 845, 10.1038/nrc1739 · DOI · Paper page
- Tan, 2009, Serum autoantibodies as biomarkers for early cancer detection, FEBS J., 276, 6880, 10.1111/j.1742-4658.2009.07396.x · DOI · Paper page
- Soussi, 2000, p53 Antibodies in the sera of patients with various types of cancer: a review, Cancer Res., 60, 1777
- Padler-Karavani, 2013, A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease, PLoS ONE., 8, e58443, 10.1371/journal.pone.0058443 · DOI · Paper page
- Choo, 2018, Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies, BMJ., 363, k4644, 10.1136/bmj.k4644 · DOI · Paper page
- Ludwig, 2018, Dietary carbohydrates: role of quality and quantity in chronic disease, BMJ., 361, k2340, 10.1136/bmj.k2340 · DOI · Paper page
Cited by
Siglecs as Immune Cell Checkpoints in Disease
Duan, S., & Paulson, J. C. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102419-035900 · Cited by 452
Insights into the role of sialylation in cancer progression and metastasis
Dobie, C., & Skropeta, D. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01126-7 · Cited by 348
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Kawanishi, K., Dhar, C., Do, R., Varki, N., Gordts, P. L. S. M., & Varki, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902902116 · Cited by 94
Self-citationGlycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
Metadata
- Authors
- Dhar, C., Sasmal, A., & Varki, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-04-17
- Volume
- 10
- ISSN
- 1664-3224
- Cited by
- 123
- References
- 22
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From "serum sickness" to "xenosialitis": past, present, and future significance of the non-human sialic acid Neu5Gc. https://app.cochat.ai/papers/10.3389/fimmu.2019.00807
- The paper
- Dhar, C., Sasmal, A., & Varki, A. (2019). From "serum sickness" to "xenosialitis": past, present, and future significance of the non-human sialic acid Neu5Gc. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.00807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.